A declaration of the vaccine developed by the University of Oxford and AstraZeneca as wholly unsafe would only delay the EU’s vaccine rollout by one month, economists have suggested.

The European Medicines Agency will issue its decision on the vaccine’s safety later on 18 March, after several countries temporarily suspended use of the drug over a small rise in blood clotting events.